Alessandra Romagnani

Results of the observational prospective RealFLOT study

Elisa Giommoni, Daniele Lavacchi, Giuseppe Tirino et al. · BMC Cancer · 2021 · 43 citations · Full text

Medicine, Oncology, Surgery +16

Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma

Tiziana Petrachi, Alessandra Romagnani, Adriana Albini et al. · Oncotarget · 2016 · 39 citations · Full text

Medicine, Oncology, Pharmacology +17

The clinical relevance of multiple DPYD polymorphisms on patients candidate for fluoropyrimidine based-chemotherapy. An Italian case-control study

Francesco Iachetta, Candida Bonelli, Alessandra Romagnani et al. · British Journal of Cancer · 2019 · 34 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Phase II study on first-line treatment of NIVolumab in combination with folfoxiri/bevacizumab in patients with Advanced COloRectal cancer RAS or BRAF mutated – NIVACOR trial (GOIRC-03-2018)

Angela Damato, Francesco Iachetta, Lorenzo Antonuzzo et al. · BMC Cancer · 2020 · 30 citations · Full text

Medicine, Immunology, Oncology +17

Phase II study of nivolumab in combination with FOLFOXIRI/bevacizumab as first-line treatment in patients with advanced colorectal cancer RAS/BRAF mutated (mut): NIVACOR trial (GOIRC-03-2018).

Angela Damato, Francesca Bergamo, Lorenzo Antonuzzo et al. · Journal of Clinical Oncology · 2022 · 21 citations

Medicine, Oncology, Pharmacotherapy +14